Health care intellectual property investor NetScientific confirmed that it had invested £0.5m in an initial public offering of portfolio company PDS Biotechnology. PDS Biotechnology had on Thursday closed an IPO that raised around $19m at $2.75 per share. NetScientific said it held about 5.75% of PDS' undiluted share capital post the offering. PDS was a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on T-cell activating technology. At 2:11pm: (LON:NSCI) Netscientific Plc share price was -0.1p at 7.75p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.